Chemistry Research Laboratory, University of Oxford, 12 Mansfield Road, Oxford OX1 3TA, UK.
Biochem Soc Trans. 2013 Aug;41(4):1037-41. doi: 10.1042/BST20130066.
In eukaryotic cells, the peak of protein phosphorylation occurs during mitosis, switching the activities of a significant proportion of proteins and orchestrating a wholesale reorganization of cell shape and internal architecture. Most mitotic protein phosphorylation events are catalysed by a small subset of serine/threonine protein kinases. These include members of the Cdk (cyclin-dependent kinase), Plk (Polo-like kinase), Aurora, Nek (NimA-related kinase) and Bub families, as well as Haspin, Greatwall and Mps1/TTK. There has been steady progress in resolving the structural mechanisms that regulate the catalytic activities of these mitotic kinases. From structural and biochemical perspectives, kinase activation appears not as a binary process (from inactive to active), but as a series of states that exhibit varying degrees of activity. In its lowest activity state, a mitotic kinase may exhibit diverse autoinhibited or inactive conformations. Kinase activation proceeds via phosphorylation and/or association with a binding partner. These remodel the structure into an active conformation that is common to almost all protein kinases. However, all mitotic kinases of known structure have divergent features, many of which are key to understanding their specific regulatory mechanisms. Finally, mitotic kinases are an important class of drug target, and their structural characterization has facilitated the rational design of chemical inhibitors.
在真核细胞中,蛋白质磷酸化的高峰期发生在有丝分裂期间,这一过程改变了相当一部分蛋白质的活性,并协调了细胞形状和内部结构的全面重组。大多数有丝分裂蛋白磷酸化事件是由一小部分丝氨酸/苏氨酸蛋白激酶催化的。这些激酶包括 Cdk(细胞周期蛋白依赖性激酶)、Plk(Polo 样激酶)、Aurora、Nek(NimA 相关激酶)和 Bub 家族的成员,以及 Haspin、Greatwall 和 Mps1/TTK。在解析调节这些有丝分裂激酶催化活性的结构机制方面已经取得了稳步进展。从结构和生化角度来看,激酶的激活似乎不是一个二元过程(从不活跃到活跃),而是一系列表现出不同程度活性的状态。在其最低活性状态下,有丝分裂激酶可能表现出多种自动抑制或非活性构象。激酶的激活通过磷酸化和/或与结合伴侣的结合来进行。这些改变结构使其形成一种几乎所有蛋白激酶共有的活性构象。然而,所有已知结构的有丝分裂激酶都具有不同的特征,其中许多特征是理解其特定调控机制的关键。最后,有丝分裂激酶是一类重要的药物靶点,其结构特征有助于合理设计化学抑制剂。